GMO.
Boston asset management firm
- Reports this week
- 1
- Active events
- 0
- Connections
- 39
What's happening
One to three months ago
-
Grantham founded the investment firm GMO, and Dalio founded the investment management firm Bridgewater Associates, both on August 14, 2026.Some support1 report
-
The investment philosophy of Warren Buffett is being discussed in relation to GMO.Some support1 report
-
Institutional investors are buying shares of the NYSEARCA:QLTY ETF.Some support1 report
Gone quiet
No new reports in 90+ days-
Grantham predicts SpaceX shares will plunge one day.Well supported5 reports
-
Jonathan Gruber criticized public misunderstanding of GMOs, coinciding with the US adopting a permissive approach to GMO regulation.Some support1 report1 development inside
-
GMO dominates U.S. corn and soybean production, with studies tainted by financial conflicts of interest.Some support1 report
-
Philip Pilkington, a former employee of the GMO fund, is currently analyzing the issues surrounding Iran's oil market.Some support1 report
-
GMO, UBS, and Capital Economics are providing market analysis and warning about potential market bubbles.Some support2 reports
-
GMO monitors gender inclusion in Rwanda while Parliament approves the national budget.Some support1 report
-
Hedge funds, including Sanctuary Advisors and Aspen Investment Management, increased their stakes in an ETF associated with GMO on June 29, 2026.Some support3 reports
-
GMO warns that the AI boom is creating the biggest bubble in US history, leading to economic downturns.Well supported7 reports
-
Fifth Third Bancorp acquired a new position in the GMO U.S. Value ETF, which was recently issued by GMO.Some support6 reports
-
Lazard Asset Management LLC lifted its stake in the GMO ETF.Some support2 reports
-
Institutional figures, including GMO co-founder Jeremy Grantham, warn of a recession and AI bubble, signaling caution in high-risk assets.Well supported4 reports
-
The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.Some support1 report
-
GMO, led by its Chairman of the Board, announced on July 21, 2025, that it pays dividends denominated in Euro.Some support1 report
-
GMO analysis suggests market strategy hinges on valuations reverting to historic mean amid concentration risk and high P/E ratios.Some support2 reports
No events began in the chosen period. Widen it, or reset.
Around GMO this week
News at the entities that move GMO most-
FDA StructuralNeurogene Inc. developed a gene therapy for Rett syndrome and received FDA agreement for a registrational trial design.Moves GMO
-
Nigeria OperationalMultiple African nations report political and social developments, including Ramaphosa's trade warnings and Shakahola convictions in Kenya.Moves GMO
-
SEC StructuralLaser Photonics Corporation hired Tim Peterman as Chief Financial Officer and engaged CBIZ for financial reporting consulting.Moves GMO
-
Fifth Third Bancorp TransactionalFifth Third Bancorp boosted its stake in the MSCI KLD 400 ETF.Moves GMO
-
OpenAI Mentioned togetherCoreWeave and OpenAI face bearish sentiment due to disappointing revenue and insufficient AI revenue to support CAPEX.Moves GMO
-
Microsoft TransactionalJim Cramer warns about yield affecting Microsoft and Nvidia shareholders as rate pressure impacts tech infrastructure costs.Moves GMO
Connections
The 22 strongest of 39, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Jeremy Grantham Structural
Jeremy Grantham is the co-founder and key figure of the investment firm GMO.
-
Philip Pilkington Structural
Pilkington was employed by the GMO fund.
-
FDA Structural
The FDA formally reviews genetic engineering products developed by GMO as part of the market approval process.
-
Nigeria Operational
GMO products are being commercialized and their market push is challenging Nigeria's national seed sovereignty.
-
Microsoft Transactional
GMO executed a significant investment by purchasing over 900,000 shares of Microsoft.
-
Lazard Asset Management LLC Transactional
Lazard Asset Management LLC divested its stake in GMO ETF.
-
Ministry of Finance and Economic Planning Operational
GMO provides functional feedback to the Ministry of Finance and Economic Planning.
-
Fifth Third Bancorp Transactional
Fifth Third Bancorp acquired a new position in GMOV, representing a financial investment transaction.
Show all 22 connections
-
SEC Structural
GMO ETF is subject to regulatory oversight and filing requirements by the SEC.
-
Rwanda Mentioned together
GMO monitors gender inclusion issues within the country of Rwanda.
-
Xavier Gabaix Mentioned together
GMO and Xavier Gabaix are noted for performing similar market analysis.
-
Capital Economics Mentioned together
Both GMO and Capital Economics publicly warned of potential market bubbles.
-
OpenAI Mentioned together
GMO cited OpenAI's share issuance as a warning sign in its financial analysis.
-
Warren Buffett Mentioned together
Both GMO and Warren Buffett are discussed in the context of investment philosophy.
-
Anthropic Mentioned together
GMO has publicly commented on the potential market risks within the AI sector where Anthropic operates.
-
UBS Mentioned together
Both GMO and UBS are noted for providing market analysis.
-
SpaceX Mentioned together
GMO provides expert analysis and tracks market trends related to SpaceX's business lifecycle and IPO.
-
Bitcoin Mentioned together
The evidence establishes that GMO was co-founded by Jeremy Grantham, a top neighbor of GMO, but provides no direct evidence of a relationship between GMO and Bitcoin.
-
Jonathan Gruber Mentioned together
Jonathan Gruber criticized the public misunderstanding regarding GMO.
-
Congress Shared context
GMO operates within the legislative and funding context of Congress, seeking appropriations.
-
Fortune Mentioned together
Both entities were observed publishing market warnings.
-
American Mentioned together
No evidence found linking GMO and American in the provided timeline.
History
Events by the month they beganAugust 2026
2 eventsJuly 2026
7 events- Institutional investors are buying shares of the NYSEARCA:QLTY ETF.
- Grantham predicts SpaceX shares will plunge one day.
- Jonathan Gruber criticized public misunderstanding of GMOs, coinciding with the US adopting a permissive approach to GMO regulation.
- GMO dominates U.S. corn and soybean production, with studies tainted by financial conflicts of interest.
- Philip Pilkington, a former employee of the GMO fund, is currently analyzing the issues surrounding Iran's oil market.
- GMO, UBS, and Capital Economics are providing market analysis and warning about potential market bubbles.
- GMO monitors gender inclusion in Rwanda while Parliament approves the national budget.
June 2026
8 events- Hedge funds, including Sanctuary Advisors and Aspen Investment Management, increased their stakes in an ETF associated with GMO on June 29, 2026.
- GMO warns that the AI boom is creating the biggest bubble in US history, leading to economic downturns.
- Fifth Third Bancorp acquired a new position in the GMO U.S. Value ETF, which was recently issued by GMO.
- Lazard Asset Management LLC lifted its stake in the GMO ETF.
- Institutional figures, including GMO co-founder Jeremy Grantham, warn of a recession and AI bubble, signaling caution in high-risk assets.
- The FDA reviewed specific genetic engineering products and published views on the issues surrounding them.
- GMO, led by its Chairman of the Board, announced on July 21, 2025, that it pays dividends denominated in Euro.
- GMO analysis suggests market strategy hinges on valuations reverting to historic mean amid concentration risk and high P/E ratios.